Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Econotherapeutics

M K Roark1, W E Reed

  • 1Owen Healthcare, Inc., Houston, TX 77036, USA.

Diagnostic Microbiology and Infectious Disease
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

This hospital pharmacy program, Econotherapeutics, controls drug costs by using antibiograms for antimicrobial prescribing. Cost data analysis supports cefotaxime over ceftriaxone for cost-effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Critical pathways.

Journal of healthcare resource management·1996
Same author

The use of drugs in renal failure.

Seminars in nephrology·1986
Same author

Sustained-release procainamide: use of serum concentrations to determine dosage.

Southern medical journal·1985
Same author

Selling Community General.

Health care strategic management·1984
Same journal

Tularemia-associated septic shock with pneumonia, lung abscesses, and pleural effusion leading to multiorgan failure: Is Francisella tularensis still a deadly pathogen in the antibiotic era? A case report.

Diagnostic microbiology and infectious disease·2026
Same journal

Impact of Xpert® MRSA/SA blood culture PCR test on antimicrobial utilization at a large teaching hospital.

Diagnostic microbiology and infectious disease·2026
Same journal

Disseminated Mucormycosis and monoclonal gammopathy in a young sarcoidosis patient following COVID-19: A rare case report.

Diagnostic microbiology and infectious disease·2026
Same journal

Human septic arthritis caused by Spiroplasma turonicum.

Diagnostic microbiology and infectious disease·2026
Same journal

Enhanced stability of RPA-CRISPR-Cas12a system for respiratory pathogen detection using Trehalose-Carboxymethyl Chitosan Lyoprotectant.

Diagnostic microbiology and infectious disease·2026
Same journal

Avian influenza H5N1: A warning signal for the next influenza pandemic.

Diagnostic microbiology and infectious disease·2026
See all related articles

Area of Science:

  • Health Economics
  • Pharmacy Management
  • Infectious Disease Management

Background:

  • The healthcare reimbursement system shifted focus from revenue to product costs.
  • Hospital pharmacy management companies face pressure to control drug expenditures.

Purpose of the Study:

  • To describe the Econotherapeutics program for controlling hospital drug costs.
  • To evaluate the cost-effectiveness of antimicrobial agents.

Main Methods:

  • Developed the Econotherapeutics program incorporating pharmacist interventions and educational initiatives.
  • Utilized hospital-specific antibiograms to guide antimicrobial prescribing.
  • Gathered centralized data to compare drug costs based on actual use across 121 hospitals.

Related Experiment Videos

Main Results:

  • Centralized data collection enabled cost comparisons of specific antimicrobial agents.
  • Actual cost data, based on dose and treatment day, were evaluated.
  • Cost data indicated cefotaxime is more cost-effective than ceftriaxone.

Conclusions:

  • The Econotherapeutics program effectively addresses drug cost control in hospitals.
  • Hospital-specific antibiograms and cost analysis are crucial for optimizing antimicrobial expenditures.
  • Evidence supports cefotaxime as a cost-effective choice over ceftriaxone.